A Safety, Tolerability and Preliminary Pharmacokinetics of BILR 355 BS Single-rising Dose Study in Healthy Male Volunteers
Clinical trial NCT02254538 · COMPLETED
Trial details
- NCT number
- NCT02254538
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Primary completion
- 2003-02-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.